High risk of abnormal QT prolongation in the early morning in diabetic and non-diabetic patients with severe hypoglycemia

References

• Cryer PE, Davis SN, Shamoon H. Hypoglycemia in diabetes. Diabetes Care. 2003;26:1902–12.
   PubMed Web of Science ®Google Scholar
• Bonds DE, Miller ME, Bergenstal RM, Buse JB, Byington RP, Cutler JA, et al. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study. BMJ. 2010;340:b4909.
   PubMed Web of Science ®Google Scholar
• Zoungas S, Patel A, Chalmers J, de Galan BE, Li Q, Billot L, et al. Severe hypoglycemia and risks of vascular events and death. N Engl J Med. 2010;363:1410–18.
   PubMed Web of Science ®Google Scholar
• Tsujimoto T, Yamamoto-Honda R, Kajio H, Kishimoto M, Noto H, Hachiya R, et al. Vital signs, QT prolongation, and newly diagnosed cardiovascular disease during severe hypoglycemia in type 1 and type 2 diabetic patients. Diabetes Care. 2014;37:217–25.
   PubMed Web of Science ®Google Scholar
• Robinson RT, Harris ND, Ireland RH, Lee S, Newman C, Heller SR. Mechanisms of abnormal cardiac repolarization during insulin-induced hypoglycemia. Diabetes. 2003;52:1469–74.
   PubMed Web of Science ®Google Scholar
• Gruden G, Giunti S, Barutta F, Chaturvedi N, Witte DR, Tricarico M, et al. QTc interval prolongation is independently associated with severe hypoglycemic attacks in type 1 diabetes from the EURODIAB IDDM complications study. Diabetes Care. 2012;35:125–7.
   PubMed Web of Science ®Google Scholar
• Christensen TF, Tarnow L, Randlov J, Kristensen LE, Struijk JJ, Eldrup E, et al. QT interval prolongation during spontaneous episodes of hypoglycaemia in type 1 diabetes: the impact of heart rate correction. Diabetologia. 2010;53:2036–41.
   PubMed Web of Science ®Google Scholar
• Gill GV, Woodward A, Casson IF, Weston PJ. Cardiac arrhythmia and nocturnal hypoglycaemia in type 1 diabetes—the ‘dead in bed’ syndrome revisited. Diabetologia. 2009;52:42–5.
   PubMed Web of Science ®Google Scholar
• Christensen TF, Cichosz SL, Tarnow L, Randlov J, Kristensen LE, Struijk JJ, et al. Hypoglycaemia and QT interval prolongation in type 1 diabetes—bridging the gap between clamp studies and spontaneous episodes. J Diabetes Complications. 2014;28:723–8.
   PubMed Web of Science ®Google Scholar
• Jones TW, Porter P, Sherwin RS, Davis EA, O’Leary P, Frazer F, et al. Decreased epinephrine responses to hypoglycemia during sleep. N Engl J Med. 1998;338:1657–62.
   PubMed Web of Science ®Google Scholar
• Tattersall RB, Gill GV. Unexplained deaths of type 1 diabetic patients. Diabet Med. 1991;8:49–58.
   PubMed Web of Science ®Google Scholar
• Thordarson H, Sovik O. Dead in bed syndrome in young diabetic patients in Norway. Diabet Med. 1995;12:782–7.
   PubMed Web of Science ®Google Scholar
• Tanenberg RJ, Newton CA, Drake AJ. Confirmation of hypoglycemia in the “dead-in-bed” syndrome, as captured by a retrospective continuous glucose monitoring system. Endocr Pract. 2010;16:244–8.
   PubMed Web of Science ®Google Scholar
• Chow E, Bernjak A, Williams S, Fawdry RA, Hibbert S, Freeman J, et al. Risk of cardiac arrhythmias during hypoglycemia in patients with type 2 diabetes and cardiovascular risk. Diabetes. 2014;63:1738–47.
   PubMed Web of Science ®Google Scholar
• Browne KF, Prystowsky E, Heger JJ, Chilson DA, Zipes DP. Prolongation of the Q-T interval in man during sleep. Am J Cardiol. 1983;52:55–9.
   PubMed Web of Science ®Google Scholar
• Bexton RS, Vallin HO, Camm AJ. Diurnal variation of the QT interval—influence of the autonomic nervous system. Br Heart J. 1986;55:253–8.
   PubMedGoogle Scholar
• Watanabe J, Suzuki Y, Fukui N, Ono S, Sugai T, Tsuneyama N, et al. Increased risk of antipsychotic-related QT prolongation during nighttime: a 24-hour holter electrocardiogram recording study. J Clin Psychopharmacol. 2012;32:18–22.
   PubMed Web of Science ®Google Scholar
• Al-Khatib SM, LaPointe NM, Kramer JM, Califf RM. What clinicians should know about the QT interval. JAMA. 2003;289:2120–7.
   PubMed Web of Science ®Google Scholar
• Veglio M, Sivieri R, Chinaglia A, Scaglione L, Cavallo-Perin P. QT interval prolongation and mortality in type 1 diabetic patients: a 5-year cohort prospective study. Neuropathy Study Group of the Italian Society of the Study of Diabetes, Piemonte Affiliate. Diabetes Care. 2000;23:1381–3.
   PubMed Web of Science ®Google Scholar
• Veglio M, Bruno G, Borra M, Macchia G, Bargero G, D’Errico N, et al. Prevalence of increased QT interval duration and dispersion in type 2 diabetic patients and its relationship with coronary heart disease: a population-based cohort. J Intern Med. 2002;251:317–24.
   PubMed Web of Science ®Google Scholar
• Giunti S, Bruno G, Lillaz E, Gruden G, Lolli V, Chaturvedi N, et al. Incidence and risk factors of prolonged QTc interval in type 1 diabetes: the EURODIAB Prospective Complications Study. Diabetes Care. 2007;30:2057–63.
   PubMed Web of Science ®Google Scholar
• Ziegler D, Zentai CP, Perz S, Rathmann W, Haastert B, Doring A, et al. Prediction of mortality using measures of cardiac autonomic dysfunction in the diabetic and nondiabetic population: the MONICA/KORA Augsburg Cohort Study. Diabetes Care. 2008;31:556–61.
   PubMed Web of Science ®Google Scholar
• Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, et al. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis. 2009;53:982–92.
   PubMed Web of Science ®Google Scholar
• Murphy NP, Ford-Adams ME, Ong KK, Harris ND, Keane SM, Davies C, et al. Prolonged cardiac repolarisation during spontaneous nocturnal hypoglycaemia in children and adolescents with type 1 diabetes. Diabetologia. 2004;47:1940–7.
   PubMed Web of Science ®Google Scholar
• Reno CM, Daphna-Iken D, Chen YS, VanderWeele J, Jethi K, Fisher SJ. Severe hypoglycemia-induced lethal cardiac arrhythmias are mediated by sympathoadrenal activation. Diabetes. 2013;62:3570–81.
   PubMed Web of Science ®Google Scholar
• Tsujimoto T, Yamamoto-Honda R, Kajio H, Kishimoto M, Noto H, Hachiya R, et al. Prediction of 90-day mortality in patients without diabetes by severe hypoglycemia: blood glucose level as a novel marker of severity of underlying disease. Acta Diabetol. 2014 Sep 7. [Epub ahead of print].
   Web of Science ®Google Scholar
• Alexopoulos D, Rynkiewicz A, Yusuf S, Johnston JA, Sleight P, Yacoub MH. Diurnal variations of QT interval after cardiac transplantation. Am J Cardiol. 1988;61:482–5.
   PubMed Web of Science ®Google Scholar
• Panza JA, Epstein SE, Quyyumi AA. Circadian variation in vascular tone and its relation to alpha-sympathetic vasoconstrictor activity. N Engl J Med. 1991;325:986–90.
   PubMed Web of Science ®Google Scholar
• Aso Y, Wakabayashi S, Nakano T, Yamamoto R, Takebayashi K, Inukai T. High serum high-sensitivity C-reactive protein concentrations are associated with relative cardiac sympathetic overactivity during the early morning period in type 2 diabetic patients with metabolic syndrome. Metabolism. 2006;55:1014–21.
   PubMed Web of Science ®Google Scholar
• Rautaharju PM, Surawicz B, Gettes LS, Bailey JJ, Childers R, Deal BJ, et al. AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part IV: the ST segment, T and U waves, and the QT interval: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society. Endorsed by the International Society for Computerized Electrocardiology. J Am Coll Cardiol. 2009;53:982–91.
   PubMed Web of Science ®Google Scholar
• Ahnve S. Correction of the QT interval for heart rate: review of different formulas and the use of Bazett’s formula in myocardial infarction. Am Heart J. 1985;109:568–74.
   PubMed Web of Science ®Google Scholar
• Hnatkova K, Malik M.“Optimum” formulae for heart rate correction of the QT interval. Pacing Clin Electrophysiol. 1999;22:1683–7.
   PubMed Web of Science ®Google Scholar